SFPM: The application for the registration and listing license of Fusidic Acid Cream has been accepted
I'm PortAI, I can summarize articles.
SFPM's wholly-owned subsidiary Harbin SFPM recently received the "Acceptance Notice" from the National Medical Products Administration regarding the application for the registration and marketing authorization of fusidic acid cream. This medication is primarily used to treat skin infections caused by various bacteria, with indications including pustules, boils, and carbuncles, suitable for facial and scalp infections
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments